 |
Autologous dermal fibroblasts genetically modified ex vivo with a lentiviral vector containing the humanCOL7A1gene |
|---|---|
| Trade Name | |
| Orphan Indication | Dystrophic epidermolysis bullosa |
| EU Market Approval | EU |
| EU Designation Date | 2016-04-28 00:00:00 |
| Sponsor | Intrexon Actobiotics N.V. |
